Application of Salivary Biomarkers in Risk Assessment for Oral Diseases in Children With Type 1 Diabetes

April 10, 2025 updated by: Bojan Petrovic, University of Novi Sad

This research contributes to a deeper understanding of the etiopathogenesis of periodontal and other oral diseases in children with T1D. By analyzing the composition of the salivary microbiome and detecting pathogenic and opportunistic microorganisms, the study aims to develop targeted preventive strategies. The findings could lead to personalized preventive programs, improving early diagnosis and oral health management in this vulnerable population.This study hypothesizes that children with Type 1 Diabetes (T1D) will exhibit significantly different oral health parameters compared to healthy peers. Specifically:

  1. Higher KEP and KEPS index values (Klein-Palmer system) indicating increased caries incidence.
  2. Higher Silness and Loe plaque index and Loe and Silness gingival index, suggesting greater plaque accumulation and gingival inflammation.
  3. Lower salivary buffering capacity and pH, potentially contributing to an increased risk of oral diseases.
  4. A distinct microbial profile, with a greater presence of pathogenic and opportunistic bacteria.
  5. A significantly higher Candida albicans count in the saliva. These findings could provide insights into the oral health challenges faced by children with T1D and guide preventive strategies.

This study explores how saliva can help assess the risk of dental and gum problems in children with Type 1 Diabetes (T1D). Researchers will analyze saliva samples to identify specific markers that may indicate a higher chance of cavities, gum disease, and oral infections. The goal is to develop early detection and prevention methods to improve oral health care for children with T1D.

The study will include 112 children aged 6 to 18. Half of them have Type 1 Diabetes, while the other half are healthy children of the same age and gender for comparison. All participants will be selected from the Clinic for Dentistry of Vojvodina, ensuring they are not currently sick and have not taken antibiotics in the past month. Children with other serious health conditions, fixed braces, or difficulty cooperating will not be included.

Researchers will examine different factors that could affect oral health in children with T1D, including saliva acidity (pH), its ability to neutralize acids, the presence of bacteria and fungi, and the condition of teeth and gums. They expect that children with T1D will have:

  1. More cavities compared to healthy children.
  2. More plaque buildup on teeth and greater gum inflammation.
  3. Lower saliva protection against acids, increasing the risk of dental problems.
  4. A different mix of bacteria in the mouth, with more potentially harmful microbes.
  5. Higher levels of the fungus Candida albicans in saliva. The findings from this study may help better understand oral health challenges in children with T1D and lead to improved prevention and treatment strategies.

Study Overview

Detailed Description

Diabetes mellitus (DM) is a metabolic disorder characterized by impaired metabolism of carbohydrates, fats, and proteins. As a chronic disease, it leads to numerous systemic complications (1). Type 1 diabetes mellitus (T1DM) most commonly affects children and adolescents, although it may also occur in adults, potentially due to modern lifestyle factors (2). The incidence and prevalence of T1DM are increasing globally, posing a significant public health and economic burden. In response, preventive programs are being developed to reduce the impact of diabetes in the general population (3). Typical symptoms of T1DM in children include frequent nocturnal urination, increased thirst, unexplained weight loss, constant hunger, hyperglycemia, blurred vision, and extreme fatigue. Additional signs may include abdominal pain, shortness of breath, or vomiting (4). In younger children, T1DM is associated with a heightened risk of diabetic ketoacidosis-the most severe and life-threatening complication of T1DM-as well as a greater risk of microvascular and macrovascular complications, often resulting in hospitalization (5).

Children and adolescents with T1DM experience absolute insulin deficiency and require lifelong exogenous insulin therapy. Treatment focuses on achieving glycemic control and preventing complications through a combination of dietary management, physical activity, and insulin therapy-delivered either via intensified insulin regimens or insulin pumps. This approach also requires frequent monitoring, regular clinical check-ups, and high levels of education and engagement from both patients and their parents (3).

The oral cavity is frequently affected by T1DM (3). Individuals with diabetes commonly experience oral health issues such as impaired taste, periodontal disease, salivary gland dysfunction, sensory disturbances, and an increased susceptibility to dental caries and oral infections (6). The properties of saliva play a crucial role in maintaining oral health and preventing caries. Saliva protects the oral tissues, provides a defense mechanism against bacteria, fungi, and viruses (7), and regulates demineralization and remineralization processes in the cariogenic environment (8). Its buffering capacity stabilizes oral pH, thereby helping to prevent enamel demineralization (8).

Insulin deficiency in T1DM leads to both qualitative and quantitative alterations in saliva, including hyposalivation and elevated salivary glucose concentrations. These changes are associated with a higher risk of caries and periodontal disease (9). Several key factors influence the development of caries, including frequent consumption of fermentable carbohydrates, poor oral hygiene, reduced fluoride intake, and the biological characteristics of saliva (10). Studies have reported increased counts of Streptococcus mutans and Lactobacillus spp. in individuals with T1DM, particularly in those with poor metabolic control, potentially due to elevated glucose levels in saliva and gingival crevicular fluid (9,11). The relationship between T1DM and periodontal health is well established. Children with T1DM, especially those with poor glycemic control, are at increased risk of developing chronic gingivitis, which tends to worsen with age (10-12). Glycosylated hemoglobin A1c (HbA1c) is a key marker used to evaluate average blood glucose levels over the preceding two to three months. The American Diabetes Association (ADA) recommends measuring HbA1c levels three to four times per year in patients with T1DM to assess metabolic control (13). According to ADA guidelines, good metabolic control in school-aged children (6-12 years) is defined by an HbA1c level <8%, while for adolescents and young adults (13-19 years), the target is <7.5%.

Studies examining the oral microbiota have shown significant differences between children with T1DM and healthy children. Notably, higher counts of periodontal pathogens, S. mutans, and Lactobacillus have been documented in children with T1DM (10-12). Reports on Candida albicans are mixed: while some studies show no significant difference, others suggest higher prevalence in children with T1DM compared to healthy controls (10). These discrepancies highlight the need for further research to clarify the impact of T1DM on the oral microbiota. Previous research has linked poor metabolic control in T1DM with increased risk for oral diseases. Risk assessment has traditionally included measures of caries prevalence, salivary flow rate, buffering capacity, and bacterial counts in stimulated saliva (11). Beyond its protective role, saliva also serves as a valuable diagnostic tool for both oral and systemic diseases. Saliva collection is simple, painless, and non-invasive, making it ideal for clinical and research use (14). Identifying reliable salivary biomarkers could contribute to the prevention, diagnosis, and prognosis of oral diseases in children with T1DM (15). Mass spectrometry (MS) has emerged as a powerful technique for comprehensive salivary proteomic analysis. It enables quantitative mapping of both host and microbial proteins in saliva (16). This highly sensitive method can identify both known and novel compounds and is increasingly applied in dental and biomedical research (17,18).

The findings from this study aim to deepen our understanding of the oral microbiota in children with T1DM and its diagnostic potential in oral disease development. By identifying specific salivary biomarkers, particularly through the use of MS, it may be possible to predict and prevent oral diseases in this vulnerable population. These insights could support the development of personalized preventive and prophylactic programs, improving both oral health and overall quality of life in children with T1DM. Ultimately, this research may help pediatric dentists tailor their clinical and preventive care to reduce the risk of oral complications in children with type 1 diabetes, while also advancing the broader understanding of the relationship between T1DM and oral health.

Study Type

Observational

Enrollment (Estimated)

112

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Novi Sad, Serbia, 21000
        • Medical Faculty, University of Novi Sad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

An experimental group will be children diagnosed with DM type 1 (at least one year), who are treated at the Novi Sad Health Center, Children's Health Care Service, and will be referred to the Department of Pediatric and Preventive Dentistry, Clinic for Dentistry of Vojvodina.

The control group includes healthy children, who match the tested group in gender and age, patients of the Clinic of Dentistry of Vojvodina

Description

Inclusion Criteria:

  • Age of subjects from 6 to 18 years, both sexes, with mixed or permanent dentition present.
  • An experimental group of at least 56 subjects will be children diagnosed with DM type 1 (at least one year)
  • The control group includes at least 56 subjects, healthy children, who match the tested group in gender and age, with the absence of acute diseases.

Exclusion Criteria:

  • Uncooperative patient
  • Associated diseases
  • Unsigned informative consent from the data subject/parent/guardian
  • Antibiotic use in the last few months
  • Subjects with orthodontic appliances

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental group
Age of subjects from 6 to 18 years, both sexes, with mixed or permanent dentition present. An experimental group of at least 56 subjects will be children diagnosed with DM type 1 (at least one year), who are treated at the Novi Sad Health Center, Children's Health Care Service, and will be referred to the Department of Pediatric and Preventive Dentistry, Clinic for Dentistry of Vojvodina. The experimental group will be divided into two subgroups: at least 28 subjects with well-regulated type 1 DM and at least 28 subjects with poorly regulated type 1 DM.
Subjects will sit in a filiological position in a dental chair. Samples of unstimulated saliva will be collected in sterile containers, salivets. A prerequisite for taking saliva samples will be that subjects do not take water and food until two hours before the examination, according to the manufacturer's instructions. SARSTED Salivette will be used. In a sterile manner, the swab will be removed from the salivette with sterile tweezers and applied to the patient's mouth on the buccal mucosa. The tampon will be held for a minimum of 2 minutes in the patient's mouth (with buccal mucosa). After the elapsed time, the tampon will be removed from the mouth, using sterile tweezers and sterile gloves and will be inserted into the saliva and closed. After sampling, the salivates will be transported to the Department of Microbiological Diagnostics of the Institute for Pulmonary Diseases of Vojvodina. Transport should be done in the shortest possible time.
Dental status in both groups of subjects will be assessed by clinical visual examination by determining the prevalence of caries of deciduous and permanent teeth using the KEP and KEPS indexes. The clinical examination will be carried out in a dental chair using artificial light-reflectors, using a dental mirror and a dental probe on all surfaces of the tooth, which are dried with air from the puster. On the basis of a dental examination, the prevalence of caries of deciduous and permanent teeth will be determined.
The assessment of the presence of dental plaque will be determined visually using the Silness and Loe plaque index, while the condition of the gingiva will be determined using the gingival index Loe and Silness . Before the examination, the subject will be advised to rinse his mouth with water to remove food residues and dental plaque. Performed in the dental chair using artificial light-reflectors, by gently pulling the dental probe over the vestibular, oral, mesial and distal surfaces of all crowns of the present teeth. Four values will be entered for each tooth. The result will be obtained by adding up all the values.
Control group
The control group includes at least 56 subjects, healthy children, who match the tested group in gender and age, patients of the Clinic of Dentistry of Vojvodina, with the absence of acute diseases. Age of subjects from 6 to 18 years, both sexes, with mixed or permanent dentition present.
Subjects will sit in a filiological position in a dental chair. Samples of unstimulated saliva will be collected in sterile containers, salivets. A prerequisite for taking saliva samples will be that subjects do not take water and food until two hours before the examination, according to the manufacturer's instructions. SARSTED Salivette will be used. In a sterile manner, the swab will be removed from the salivette with sterile tweezers and applied to the patient's mouth on the buccal mucosa. The tampon will be held for a minimum of 2 minutes in the patient's mouth (with buccal mucosa). After the elapsed time, the tampon will be removed from the mouth, using sterile tweezers and sterile gloves and will be inserted into the saliva and closed. After sampling, the salivates will be transported to the Department of Microbiological Diagnostics of the Institute for Pulmonary Diseases of Vojvodina. Transport should be done in the shortest possible time.
Dental status in both groups of subjects will be assessed by clinical visual examination by determining the prevalence of caries of deciduous and permanent teeth using the KEP and KEPS indexes. The clinical examination will be carried out in a dental chair using artificial light-reflectors, using a dental mirror and a dental probe on all surfaces of the tooth, which are dried with air from the puster. On the basis of a dental examination, the prevalence of caries of deciduous and permanent teeth will be determined.
The assessment of the presence of dental plaque will be determined visually using the Silness and Loe plaque index, while the condition of the gingiva will be determined using the gingival index Loe and Silness . Before the examination, the subject will be advised to rinse his mouth with water to remove food residues and dental plaque. Performed in the dental chair using artificial light-reflectors, by gently pulling the dental probe over the vestibular, oral, mesial and distal surfaces of all crowns of the present teeth. Four values will be entered for each tooth. The result will be obtained by adding up all the values.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of dental caries and periodontal disease
Time Frame: From 31 January 2025 to January 2026
The primary outcome of the study is the prevalence of dental caries and periodontal diseases in children with type 1 diabetes, compared to non-diabetic children. Caries prevalence will be defined using KEP and KEPS indexes according to the Klein-Palmer system and assessment of the amount of dental plaque using the Silness and Loe plaque index and assessment of gingival condition using the gingival index Loe and Silness .
From 31 January 2025 to January 2026
Microbiological analysis
Time Frame: From 31 January 2025 to January 2026
The primary outcome of this clinical research is to evaluate the feasibility and effectiveness of collecting unstimulated saliva samples for microbiological procedures and analysis. Specifically, the study aims to determine whether unstimulated saliva can serve as a reliable diagnostic medium for the identification and characterization of isolated microorganisms present in the oral cavity. The identification of these microorganisms will be carried out using standard microbiological techniques to assess the microbial composition and potential pathogenic species. Outcomes will be measured based on data provided after experimental part.
From 31 January 2025 to January 2026

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saliva chek buffer
Time Frame: From 31 January 2025 to January 2026.

Evaluation of the characteristics of stimulated saliva - buffering capacity of saliva in children with DM type 1 and healthy subjects.

Invitro test for cheking buffering capacity of saliva using saliva from collection cup. Final results will be calculated by adding the points from 0-12 according to the final colour of each pad.

From 31 January 2025 to January 2026.
Saliva ph measurement
Time Frame: From 31 January 2025 to January 2026
In vitro test for ph measurement of saliva. According to the manufacturer's instructions using ph test strip and pooled saliva expectorated in the collection cup. Measuring the pH value of saliva using a factory-made color scale and determining the pH of saliva on a scale from 5.0 to 7.8.
From 31 January 2025 to January 2026

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire
Time Frame: From 31 January 2025 to January 2026

Oral health related quality of life, as reported through validated questionnaires or surveys in studies, to assess how dental caries and diabetes management affect overall well-being.

Outcomes will be measured based on data provided after experimental part. Measures of effect.

From 31 January 2025 to January 2026

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2025

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

April 2, 2025

First Submitted That Met QC Criteria

April 10, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 10, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biomarkers

Clinical Trials on Taking saliva samples of unstimulated saliva will be collected in sterile containers, salivets.

Subscribe